Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.3 USD | +1.98% | -1.93% | -24.71% |
04-23 | Genscript Biotech Unit Gets Approval for Blood Cancer Drug by European Commission | MT |
04-22 | Legend Biotech's Carvykti Gets European Commission Approval for Treatment of Blood Cancer | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 56.36 | 56.36 | 58.11 |
Spread/Res. | -19.62% | -19.62% | -22.04% |
Spread/Supp. | +1.98% | +1.98% | +1.77% |
Support | 44.42 | 44.42 | 44.51 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LEGN Stock
- Charts Legend Biotech Corporation